Aspartase mutants and their use in r-3-aminobutyric acid synthesis
By modifying the aspartic acid enzyme mutant and using high-density fermentation technology, and optimizing catalytic conditions, the problems of long production time and high cost of R-3-aminobutyric acid in existing technologies have been solved, and efficient and low-cost industrial production has been achieved.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- MEIBANG MEIHE BIOTECHNOLOGY CO LTD
- Filing Date
- 2022-10-31
- Publication Date
- 2026-06-12
AI Technical Summary
Existing chemical synthesis and bioenzymatic methods for producing R-3-aminobutyric acid suffer from problems such as long reaction times, high costs, severe pollution, and low conversion rates, making it difficult to achieve large-scale industrialization.
By designing aspartic acid mutants through molecular modification, combining high-density fermentation technology, and optimizing catalytic conditions, a new bio-enzymatic method for the production of R-3-aminobutyric acid was developed. The modified aspartic acid mutants can efficiently catalyze the synthesis of R-3-aminobutyric acid in a short time.
It achieves high conversion and high selectivity in the synthesis of R-3-aminobutyric acid, shortens the reaction time, reduces production costs, and is suitable for large-scale industrial production.